Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kramar

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
BMC Medical Research Methodology|July 25, 2012
What does a modified-Fibonacci dose-escalation actually correspond to?Nicolas Penel, Andrew Kramar
Bulletin Du Cancer|December 7, 2007
[Interim analyses]Andrew Kramar, Xavier Paoletti
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 17, 2008
Early stopping rules in clinical trials based on sequential monitoring of serious adverse eventsAndrew Kramar, C Bascoul-Mollevi
Molecular Oncology|February 26, 2011
Multidimensionality of microarrays: statistical challenges and (im)possible solutionsStefan Michiels, Andrew Kramar, Serge Koscielny
Bulletin Du Cancer|May 6, 2014
What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trialsNicolas Penel, Thomas Ryckewaert, Andrew Kramar
Computer Methods and Programs in Biomedicine|March 13, 2012
Designing group sequential randomized clinical trials with time to event end points using a R functionThomas Filleron, Jocelyn Gal, Andrew Kramar
Computer Methods and Programs in Biomedicine|August 28, 2007
np1: a computer program for dose escalation strategies in phase I clinical trialsAndrew Kramar, Nadine Houédé, Xavier Paoletti
Lancet (London, England)|January 9, 2003
Open versus laparoscopy-assisted colectomySerge Evrard, Simone Mathoulin-Pélissier, Andrew Kramar
Bulletin Du Cancer|March 28, 2003
[Laparoscopy treatment of colon cancer: ducking is no fair play!]Serge Evrard, Simone Mathoulin-Pélissier, Andrew Kramar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Relationship of serum bilirubin to toxicity in patients with metastatic colorectal cancer treated with single-agent high-dose irinotecanAndrew Kramar, Sophie Gourgou-Bourgade, Marc Ychou
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
BMC Medical Research Methodology|July 25, 2012
What does a modified-Fibonacci dose-escalation actually correspond to?Nicolas Penel, Andrew Kramar
Bulletin Du Cancer|December 7, 2007
[Interim analyses]Andrew Kramar, Xavier Paoletti
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 17, 2008
Early stopping rules in clinical trials based on sequential monitoring of serious adverse eventsAndrew Kramar, C Bascoul-Mollevi
Molecular Oncology|February 26, 2011
Multidimensionality of microarrays: statistical challenges and (im)possible solutionsStefan Michiels, Andrew Kramar, Serge Koscielny
Bulletin Du Cancer|May 6, 2014
What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trialsNicolas Penel, Thomas Ryckewaert, Andrew Kramar
Computer Methods and Programs in Biomedicine|March 13, 2012
Designing group sequential randomized clinical trials with time to event end points using a R functionThomas Filleron, Jocelyn Gal, Andrew Kramar
Computer Methods and Programs in Biomedicine|August 28, 2007
np1: a computer program for dose escalation strategies in phase I clinical trialsAndrew Kramar, Nadine Houédé, Xavier Paoletti
Lancet (London, England)|January 9, 2003
Open versus laparoscopy-assisted colectomySerge Evrard, Simone Mathoulin-Pélissier, Andrew Kramar
Bulletin Du Cancer|March 28, 2003
[Laparoscopy treatment of colon cancer: ducking is no fair play!]Serge Evrard, Simone Mathoulin-Pélissier, Andrew Kramar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Relationship of serum bilirubin to toxicity in patients with metastatic colorectal cancer treated with single-agent high-dose irinotecanAndrew Kramar, Sophie Gourgou-Bourgade, Marc Ychou
Pageof 9